Literature DB >> 34267478

Development of Acquired Hemophilia A After Treatment of Bronchial Asthma with Benralizumab.

Hiroaki Kitamura1, Yasushi Kubota2, Rika Tomimasu1, Haruki Hirakawa1, Hiroshi Inoue1, Hitomi Umeguchi1, Moeko Yoshida3, Hideki Akahoshi3, Shiho Tsuruda3, Rie Ide3, Shinya Kimura2, Masaharu Miyahara1.   

Abstract

Entities:  

Year:  2020        PMID： 34267478      PMCID： PMC8239068          DOI： 10.1007/s12288-020-01371-z

Source DB:  PubMed          Journal:  Indian J Hematol Blood Transfus        ISSN： 0971-4502            Impact factor:   0.915


× No keyword cloud information.
  7 in total

Review 1.  Acquired hemophilia A: a review of recent data and new therapeutic options.

Authors:  Massimo Franchini; Stefania Vaglio; Giuseppe Marano; Carlo Mengoli; Sara Gentili; Simonetta Pupella; Giancarlo Maria Liumbruno
Journal:  Hematology       Date:  2017-04-25       Impact factor: 2.269

Review 2.  Acquired hemophilia a: a current review of autoantibody disease.

Authors:  Douglas W Sborov; George M Rodgers
Journal:  Clin Adv Hematol Oncol       Date:  2012-01

3.  A method for estimating the probability of adverse drug reactions.

Authors:  C A Naranjo; U Busto; E M Sellers; P Sandor; I Ruiz; E A Roberts; E Janecek; C Domecq; D J Greenblatt
Journal:  Clin Pharmacol Ther       Date:  1981-08       Impact factor: 6.875

4.  A shift towards a T cell cytokine deficiency along with an anti-inflammatory/regulatory microenvironment may enable the synthesis of anti-FVIII inhibitors in haemophilia A patients.

Authors:  D G Chaves; C Velloso-Rodrigues; C A Oliveira; A Teixeira-Carvalho; M M Santoro; O A Martins-Filho
Journal:  Clin Exp Immunol       Date:  2010-09-15       Impact factor: 4.330

Review 5.  FVIII inhibitors: pathogenesis and avoidance.

Authors:  Jan Astermark
Journal:  Blood       Date:  2015-02-23       Impact factor: 22.113

6.  Reductions in eosinophil biomarkers by benralizumab in patients with asthma.

Authors:  Tuyet-Hang Pham; Gautam Damera; Paul Newbold; Koustubh Ranade
Journal:  Respir Med       Date:  2016-01-08       Impact factor: 3.415

7.  A Polymorphism in the IL-5 Gene is Associated with Inhibitor Development in Severe Hemophilia A Patients.

Authors:  Inanç Değer Fidancı; Bülent Zülfikar; Kaan Kavaklı; M Cem Ar; Yurdanur Kılınç; Zafer Başlar; Server Hande Cağlayan
Journal:  Turk J Haematol       Date:  2014-03-05       Impact factor: 1.831
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.